Influenza vaccine: 70 mil. doses available for 1995-1996; Connaught does not foresee shortages.
SEVENTY MIL. DOSES OF INFLUENZA VACCINE WILL BE AVAILABLE FOR 1995-96 flu season, according to an estimate from FDA Office of Vaccine Research and Review Medical Officer Peter Patriarca, MD, and Centers for Disease Control & Prevention staffer Raymond Strikas, MD. The vaccines will be available from such manufacturers as Connaught and Wyeth-Ayerst (FluShield). There are about 60 mil. elderly people in the U.S., who are considered at risk for influenza complications.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth